These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 17319461)

  • 41. Role of adipose tissue for cardiovascular-renal regulation in health and disease.
    Engeli S; Sharma AM
    Horm Metab Res; 2000; 32(11-12):485-99. PubMed ID: 11246814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Chronic activation of sympathetic nervous system and systemic hypertension--stress shows the way.
    Fontes MA; Xavier CH
    J Appl Physiol (1985); 2010 Dec; 109(6):2004-5. PubMed ID: 21188815
    [No Abstract]   [Full Text] [Related]  

  • 43. The sympathetic nervous system and hypertension: recent developments.
    DiBona GF
    Hypertension; 2004 Feb; 43(2):147-50. PubMed ID: 14707153
    [No Abstract]   [Full Text] [Related]  

  • 44. Pathophysiology and treatment of obesity hypertension.
    Wofford MR; Hall JE
    Curr Pharm Des; 2004; 10(29):3621-37. PubMed ID: 15579059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leptin and hyperleptinemia - from friend to foe for cardiovascular function.
    Ren J
    J Endocrinol; 2004 Apr; 181(1):1-10. PubMed ID: 15072562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Obesity and hypertension].
    Verdecchia P; Trimarco B
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):54S-59S. PubMed ID: 18773751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertension in obesity: is leptin the culprit?
    Simonds SE; Cowley MA
    Trends Neurosci; 2013 Feb; 36(2):121-32. PubMed ID: 23333346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Rohrwasser A
    J Appl Physiol (1985); 2010 Dec; 109(6):2007. PubMed ID: 21188818
    [No Abstract]   [Full Text] [Related]  

  • 49. Sympathetic nervous system and insulin resistance: from obesity to diabetes.
    Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Dominant contributors for systemic hypertension--who leads, who follows?
    Braga VA
    J Appl Physiol (1985); 2010 Dec; 109(6):2007-8. PubMed ID: 21188840
    [No Abstract]   [Full Text] [Related]  

  • 51. Factors Responsible for Obesity-Related Hypertension.
    Lim K; Jackson KL; Sata Y; Head GA
    Curr Hypertens Rep; 2017 Jul; 19(7):53. PubMed ID: 28551830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leptin as a Mediator of Obesity-Induced Hypertension.
    Bell BB; Rahmouni K
    Curr Obes Rep; 2016 Dec; 5(4):397-404. PubMed ID: 27665107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases.
    Balasubramanian P; Hall D; Subramanian M
    Geroscience; 2019 Feb; 41(1):13-24. PubMed ID: 30519806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of leptin in blood pressure regulation and arterial hypertension.
    Bełtowski J
    J Hypertens; 2006 May; 24(5):789-801. PubMed ID: 16612235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Systemic hypertension--a "ratologist" point of view.
    Julien C
    J Appl Physiol (1985); 2010 Dec; 109(6):2004. PubMed ID: 21188799
    [No Abstract]   [Full Text] [Related]  

  • 56. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Cohn JN
    J Appl Physiol (1985); 2010 Dec; 109(6):2006-7. PubMed ID: 21188834
    [No Abstract]   [Full Text] [Related]  

  • 57. Cardiovascular and sympathetic effects of leptin.
    Rahmouni K; Haynes WG; Mark AL
    Curr Hypertens Rep; 2002 Apr; 4(2):119-25. PubMed ID: 11884267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is obesity a major cause of chronic kidney disease?
    Hall JE; Henegar JR; Dwyer TM; Liu J; Da Silva AA; Kuo JJ; Tallam L
    Adv Ren Replace Ther; 2004 Jan; 11(1):41-54. PubMed ID: 14730537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leptin and heart sympathetic activity in normotensive obese and non-obese subjects.
    Amador N; Pérez-Luque E; Malacara JM; Guízar JM; Paniagua R; Lara S
    Ital Heart J; 2004 Jan; 5(1):29-35. PubMed ID: 15080578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.